Cybin INC. (HELP) SEC Filings — 2024
50 SEC filings for Cybin INC. (HELP) in 2024.
Filings
- Cybin Inc. Files Form 6-K — 6-K · Dec 10, 2024
- Cybin Inc. Files Form 6-K — 6-K · Dec 4, 2024
- Cybin INC. SC 13G Filing — SC 13G · Dec 3, 2024
- Cybin Inc. Reports Positive 12-Month Data for CYB003 — 6-K · Nov 18, 2024
- Cybin Inc. Files Form 6-K with News Release — 6-K · Nov 14, 2024
- Cybin INC. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Cybin INC. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Cybin Inc. Files 6-K, Incorporates Exhibits into F-10 — 6-K · Nov 13, 2024
- Cybin Inc. Files 6-K, CEO Attends Health Summit — 6-K · Nov 1, 2024
- Cybin Inc. Files 6-K with Patent News — 6-K · Oct 24, 2024
- Cybin Inc. Files 6-K Report with October 3rd News Release — 6-K · Oct 3, 2024
- Cybin Inc. Files Form 6-K with News Release — 6-K · Oct 1, 2024
- Cybin Inc. Files 6-K Report with News Release — 6-K · Sep 24, 2024
- Cybin Inc. Files 6-K, Incorporates Exhibits — 6-K · Sep 20, 2024
- Cybin Inc. Raises $25.2M in Public Offering — 6-K · Sep 20, 2024
- Cybin Inc. Files Form 6-K — 6-K · Sep 4, 2024
- Cybin Inc. Files 6-K Report — 6-K · Aug 29, 2024
- Cybin Inc. Files 6-K, Reports News Release — 6-K · Aug 28, 2024
- Cybin INC. SC 13G Filing — SC 13G · Aug 27, 2024
- Cybin Inc. Files August 2024 Report on Form 6-K — 6-K · Aug 15, 2024
- Cybin Inc. Files 6-K with August 13 News Release — 6-K · Aug 13, 2024
- Cybin Inc. Files 6-K, Incorporates Exhibits — 6-K · Aug 8, 2024
- Cybin Inc. to Present at Canaccord Genuity Conference — 6-K · Aug 7, 2024
- Cybin Inc. Files 6-K for Shareholder Meeting Notice — 6-K · Jul 5, 2024
- Cybin Inc. Files 6-K, Incorporates Exhibit 99.1 — 6-K · Jun 26, 2024
- Cybin Inc. to Present at Two Major Conferences — 6-K · Jun 20, 2024
- Cybin Inc. Appoints New Chief Medical Officer — 6-K · Jun 11, 2024
- Cybin Inc. to Present at Cantor Fitzgerald Health Conference — 6-K · May 29, 2024
- Cybin Inc. Announces Shareholder Meeting Participation — 6-K · May 14, 2024
- Cybin Inc. Files Form 6-K with May 6 News Release — 6-K · May 6, 2024
- Cybin Inc. to Present at Milken Institute Global Conference — 6-K · Apr 25, 2024
- Cybin Inc. Files 6-K, Incorporates Exhibit 99.1 — 6-K · Apr 18, 2024
- Cybin to Present EMBARK Study Data at ASCP Meeting — 6-K · Apr 18, 2024
- Cybin Inc. Secures US Patent for CY003, Raises $25M — 6-K · Apr 16, 2024
- Cybin Inc. Files 6-K, CEO to Present at Burton Conference — 6-K · Apr 10, 2024
- Cybin INC. SC 13G Filing — SC 13G · Mar 25, 2024
- Cybin INC. SC 13G Filing — SC 13G · Mar 22, 2024
- Cybin Inc. Files 6-K, Incorporates Exhibit 99.1 — 6-K · Mar 22, 2024
- Cybin Inc. Files 6-K with Agency Agreement — 6-K · Mar 21, 2024
- Cybin Inc. Secures $30M in Private Placement — 6-K · Mar 20, 2024
- Cybin Inc. to Present at Oppenheimer Healthcare Conference — 6-K · Mar 18, 2024
- Cybin Initiates Phase 2 Study for MDD Treatment — 6-K · Mar 15, 2024
- Cybin Inc. Files 6-K, Reports News Release — 6-K · Mar 14, 2024
- Cybin Inc. Files 6-K Report with March 12 News Release — 6-K · Mar 13, 2024
- Cybin Files 6-K, Details Cowen Conference News Release — 6-K · Feb 27, 2024
- Cybin Inc. Incorporates Exhibits into F-10 Registration Statement — 6-K · Feb 14, 2024
- Cybin INC. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Cybin Secures Two New DMT Patents in Japan, Bolstering IP Portfolio — 6-K · Feb 7, 2024
- CYBIN: FDA Clears Phase 2a Study for CYB004 in Anxiety Disorder — 6-K · Jan 23, 2024
- Cybin's Deuterated DMTs Show Positive Phase 1 Data, GAD Study Q1 2024 — 6-K · Jan 8, 2024